Q-Cells

BIOLOGICAL2 trials

Sponsors

Q Therapeutics, Inc.

Conditions

Amyotrophic Lateral SclerosisTransverse Myelitis

Phase 1

Study to Investigate the Safety of the Transplantation (by Injection) of Human Glial Restricted Progenitor Cells (hGRPs; Q-Cells®) Into Subjects With Amyotrophic Lateral Sclerosis (ALS)

Not yet recruitingNCT02478450

Q Therapeutics, Inc.Amyotrophic Lateral Sclerosis

Start: 2026-12-01End: 2029-12-01Target: 30Updated: 2026-07-08

Study to Investigate the Safety of the Transplantation of Human Glial Restricted Progenitor Cells Into Subjects With Transverse Myelitis

RecruitingNCT03887273

Q Therapeutics, Inc.Transverse Myelitis

Start: 2022-09-20End: 2028-12-01Target: 9Updated: 2026-07-21